trending Market Intelligence /marketintelligence/en/news-insights/trending/U8nhv4CePBLfFGAFC94uKA2 content esgSubNav
In This List

Viking Therapeutics prices $12.8M common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Viking Therapeutics prices $12.8M common stock offering

Viking Therapeutics Inc. priced a public offering of 5,130,435 common shares at $2.50 apiece to raise $12.8 million in gross proceeds.

William Blair & Co. LLC is acting as sole book-running manager for the offering, with Maxim Group LLC and Roth Capital Partners acting as co-managers.

The offering's underwriters can buy up to an additional 769,565 of the shares offered.

The offering, which is expected to close by Dec. 11, will help raise funds for the development of the company's product pipeline.